Editas Medicine (EDIT) FCF Margin (2015 - 2025)
Editas Medicine (EDIT) posted quarterly FCF Margin of 408.88% for Q3 2025, up 9058948.0% year-over-year from N/an in Q3 2024, and up 70.86% quarter-over-quarter from 1403.35% in Q2 2025.
Powered by 
Analysis
Editas Medicine (EDIT) FCF Margin (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported FCF Margin for 11 consecutive years, with 408.88% the latest figure, recorded in Q3 2025.
- In Q3 2025, FCF Margin rose 9058948.0% year-over-year to 408.88%; the TTM figure through Sep 2025 stood at 386.2% (down 7635.0% YoY), while the FY2024 annual figure was 678.07%, down 50283.0% from the prior year.
- FCF Margin rose to 408.88% in Q3 2025 per EDIT's latest filing, from 1403.35% in the prior quarter.
- Across five years, FCF Margin topped out at 39.21% in Q4 2023 and bottomed at 115757.14% in Q3 2022.
- Historically, FCF Margin has averaged 12783.15% across 5 years, with a median of 760.23% in 2022.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 11506118 bps — and 2023, when it surged 11508814 bps.
- Editas Medicine's FCF Margin stood at 300.16% in 2021, then plunged by 119 bps to 656.32% in 2022, then jumped by 94 bps to 39.21% in 2023, then sank by 327 bps to 167.63% in 2024, then tumbled by 144 bps to 408.88% in 2025.
- Business Quant data shows EDIT's FCF Margin at 408.88% in Q3 2025, 1403.35% in Q2 2025, and 1004.16% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Editas Medicine | 287.84 Mn | 141.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -408.88% |
| Jun 30, 2025 | -1,403.35% |
| Mar 31, 2025 | -1,004.16% |
| Dec 31, 2024 | -167.63% |
| Sep 30, 2024 | -90,998.36% |
| Jun 30, 2024 | -11,804.29% |
| Mar 31, 2024 | -4,558.85% |
| Dec 31, 2023 | -39.21% |
| Sep 30, 2023 | -669.00% |
| Jun 30, 2023 | -1,387.05% |
| Mar 31, 2023 | -381.77% |
| Dec 31, 2022 | -656.32% |
| Sep 30, 2022 | -115,757.14% |
| Jun 30, 2022 | -604.79% |
| Mar 31, 2022 | -760.23% |
| Dec 31, 2021 | -300.16% |
| Sep 30, 2021 | -695.97% |
| Jun 30, 2021 | -10,490.77% |
| Mar 31, 2021 | -791.88% |
| Dec 31, 2020 | -363.22% |